This study was undertaken to validate a set of candidate biomarkers of seizure susceptibility in a retrospective, multisite case-control study, and to determine the robustness of these biomarkers derived from routinely collected electroencephalography (EEG) within a large cohort (both epilepsy and common alternative conditions such as nonepileptic attack disorder).

Luke Tait, Lydia E. Staniaszek, Elizabeth Galizia, David Martin-Lopez, Matthew C. Walker, Al Anzari Abdul Azeez, Kay Meiklejohn, David Allen, Chris Price, Sophie Georgiou, Manny Bagary, Sakh Khalsa, Francesco Manfredonia, Phil Tittensor, Charlotte Lawthom, Benjamin B. Howes, Rohit Shankar, John R. Terry, Wessel Woldman